OLBA HEALTHCARE (2689) Q1 2026 earnings summary

Executive summary

• Net sales for the three months ended September 30, 2025, increased by 6.1% year-over-year to ¥30,824 million.

• Operating profit declined by 7.3% year-over-year to ¥258 million, and ordinary profit decreased by 10.0% to ¥255 million.

• Profit attributable to owners of parent was ¥166 million, down 0.8% year-over-year.

• Comprehensive income fell 13.7% year-over-year to ¥138 million.

Financial highlights

• Gross profit for the quarter was ¥3,264 million, down from ¥3,375 million in the prior year.

• Basic earnings per share for the quarter was ¥28.14, compared to ¥28.42 a year earlier.

• Total assets as of September 30, 2025, were ¥46,510 million, up from ¥45,871 million at June 30, 2025.

• Net assets decreased to ¥11,905 million from ¥12,255 million at the end of the previous quarter.

Outlook and guidance

• Full-year net sales forecast for fiscal year ending June 30, 2026, is ¥127,978 million, up 4.3% year-over-year.

• Operating profit is projected at ¥2,000 million, ordinary profit at ¥1,928 million, and profit attributable to owners of parent at ¥1,321 million, down 7.6% year-over-year.

• Basic earnings per share for the full year is forecast at ¥223.04.

• Dividend forecast remains unchanged at ¥80.00 per share for the year.